SAN ANTONIO -- More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen ...
Just weeks after undergoing robotic surgery at Doncaster Royal Infirmary, lorry driver Michael Smethurst is back ...